CL2007003841A1 -
COMPOUNDS DERIVED FROM 4 (5H-1 LAMBDA-TIAZOL-2-IL) PIPERIDINE; PHARMACEUTICAL COMPOSITION CONTAINING THESE COMPOUNDS; AND ITS USE TO TREAT DIABETES.
- Google Patents
COMPOUNDS DERIVED FROM 4 (5H-1 LAMBDA-TIAZOL-2-IL) PIPERIDINE; PHARMACEUTICAL COMPOSITION CONTAINING THESE COMPOUNDS; AND ITS USE TO TREAT DIABETES.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filedlitigationCriticalhttps://patents.darts-ip.com/?family=40261614&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2007003841(A1)"Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Metabolex IncfiledCriticalMetabolex Inc
Publication of CL2007003841A1publicationCriticalpatent/CL2007003841A1/en
CL2007003841A2006-12-282007-12-27
COMPOUNDS DERIVED FROM 4 (5H-1 LAMBDA-TIAZOL-2-IL) PIPERIDINE; PHARMACEUTICAL COMPOSITION CONTAINING THESE COMPOUNDS; AND ITS USE TO TREAT DIABETES.
CL2007003841A1
(en)
COMPOUNDS DERIVED FROM SUBSTITUTED PYRIMIDINS; PROCEDURE FOR THE PREPARATION OF SUCH COMPOUNDS; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUNDS; AND ITS USE TO TREAT HEMATOLOGICAL DISORDERS.
COMPOUNDS DERIVED FROM PYRIDOPIRIMIDINONES; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUNDS; AND ITS USE TO TREAT PAIN, DEPRESSION, CARDIOVASCULAR DISEASES, RESPIRATORY DISEASES AND PSYCHIATRIC DISEASES.
COMPOUNDS DERIVED FROM BICYCLES, CEPT INHIBITORS; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUNDS; AND ITS USE TO TREAT HYPERLIPIDEMIA, ARTERIOESCLEROSIS, AMONG OTHER ILLNESSES.
COMPOUNDS DERIVED FROM 3,5-DIOXI-BENZAMIDA; PREPARATION PROCESS; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUNDS; AND ITS USE TO TREAT A MEDIUM DISEASE THROUGH GLK, SUCH AS TYPE 2 DIABETES.
COMPOUNDS DERIVED FROM NICOTINAMIDE, INHIBITORS OF 11BETAHSD1; PREPARATION PROCESS; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUNDS; AND ITS USE TO TREAT METABOLIC SYNDROME, TYPE 2 DIABETES, OBESITY OR ATEROSCLEROSIS.
COMPOUNDS DERIVED FROM 2,4-DIAMINO PIRIMIDINA, ANTRANILAMIDE INHIBITORS OF CINASA AURORA; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUNDS; AND ITS USE TO TREAT CANCER.
COMPOUNDS DERIVED FROM 2-METILSULFONIL-1,2,3,4-TETRAHYDROISOQUINOLINE; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUNDS; AND ITS USE TO TREAT DIABETES, HYPERLIPIDEMIA, CARDIAC DISEASES, ARTHRITIS, OSTEOPOROSIS, HYPERTENSION, CATARA
COMPOUNDS DERIVED FROM MORFOLINO PIRIMIDINA; PHARMACEUTICAL COMPOSITION; AND ITS USE TO PREPARE A MEDICINAL PRODUCT TO PRODUCE AN ANTIPROLIFERING EFFECT.
COMPOUNDS DERIVED FROM 5-HYDROXIMETHYL OXAZOLIDIN-2-ONA; PHARMACEUTICAL COMPOSITION CONTAINING THESE COMPOUNDS; AND ITS USE TO TREAT AND PREVENT BACTERIAL INFECTIONS.
COMPOUNDS DERIVED FROM PIRAZOLILTIENOPIRIDINAS; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUND; AND USE OF THE COMPOUND IN THE INHIBITION OF ESCARAS.
METFORMIN COMPOUND R - (+) LIPOATE; MIXTING THAT METFORMIN AND ACID R - (+) LIPOIC; PHARMACEUTICAL COMPOSITION THAT INCLUDES THE COMPOUND; METHOD FOR PREPARING THE COMPOUND; KIT; AND USE TO TREAT DIABETES.
COMPOUNDS DERIVED FROM SULFONIL-FENIL-2H- [1,2,4] OXADIAZOL-5-ONA; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUND; PREPARATION PROCEDURE; AND USE OF THE COMPOUND IN THE TREATMENT OF METABOLISM DISORDERS, AS DIABETES MELLITUS, DIS